With no biology degree and just $3,000, he designed a personalized mRNA vaccine in a world first. Moderna and Merck are ...
A triple drug approach that blocks the KRAS pathway at three points eliminated pancreatic tumors and prevented resistance in ...
With no biology degree and just $3,000, he designed a personalized mRNA vaccine in a world first. Moderna and Merck are spending billions to bring the same technology to human patients.
3 天on MSN
New atlas that charts tumor cell diversity could guide personalized therapy for head and neck cancer
Head and neck squamous cell carcinomas (HNSCC) are the seventh-most prevalent form of cancer and are associated with human ...
An enigmatic type of circulating tumor cell called a dual-positive (DP) cell is associated with shorter survival time in patients with advanced breast cancer, according to a study led by investigators ...
Morning Overview on MSN
Study finds microplastics in 90% of prostate cancer tumors
Researchers at NYU Langone Health have detected tiny plastic fragments in nine out of 10 prostate cancer tumors examined, a ...
When Jon and Dayla Culp received the news that their six-year-old Labrador retriever, Clarice, had a malignant tumor near her ...
Scientists are developing cancer-eating bacteria designed to grow inside oxygen-free tumors and attack cancer from within.
MedPage Today on MSN
Bubbles of prostate cancer info; cancer drug tops moneymakers; small kidney tumors
News, features, and commentary about cancer-related issues ...
For five decades, scientists have known about a notorious cancer-causing enzyme called SRC. But they always assumed it only ...
Colorectal cancer (CRC) remains one of the most prevalent malignancies and a leading cause of cancer-related mortality worldwide. Beyond tumor-intrinsic ...
A man successfully developed a mRNA cancer vaccine for his dog with the help of AI, and medical science is stunned.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果